SF3566 (Legislative Session 94 (2025-2026))
Treatments that may harm fertility informed consent requirement provision
AI Generated Summary
Purpose
- The bill would require health care providers to obtain informed, written consent before performing medical treatments that may harm a patient’s fertility. It aims to ensure patients are informed about potential fertility risks and have access to information and options related to fertility preservation and family building.
Definitions (key terms)
- Family building: How a person forms a family, including both biological and nonbiological steps.
- Fertility: The ability to conceive or carry biological children.
- Fertility specialist: A health care provider with expertise in reproductive health and fertility preservation.
- Health care provider: A licensed or registered health professional practicing within their licensed scope and state law.
- Medical treatment: Any prescription drug, procedure, therapy, or intervention that may impact fertility.
- Patient: The person receiving medical treatment.
Main Provisions
Informed consent requirement:
- A health care provider must discuss with the patient the potential harm a treatment could have on the patient’s fertility.
- The provider must give the patient an opportunity to consult with a fertility specialist about the treatment’s impact, fertility preservation options, and family building options.
- The patient must give prior written informed consent, affirming they were informed about the fertility risks, understood them, and authorize the treatment.
Prohibited conduct:
- Providers must not influence a patient’s decision by discouraging the patient from consulting a fertility specialist or exploring fertility preservation or family-building options.
Disciplinary action:
- A health care provider who violates the requirements could face disciplinary action from the relevant licensing board.
- A patient harmed by the violation may file a complaint with the appropriate licensing board.
Oversight and monitoring:
- The commissioner of health must establish procedures to monitor compliance with these requirements.
Significance and Potential Impact
- Establishes a formal, patient-centered process to consider fertility impacts before treatment.
- Requires proactive discussion and access to fertility-related information and services.
- Introduces accountability through licensing boards and state health oversight.
- May influence how health care providers counsel patients and obtain consent for treatments with fertility implications.
How this changes existing law
- Creates a new state requirement for informed consent specifically tied to treatments that may affect fertility.
- Adds defined terms related to fertility, preservation, and family building to guide practice.
- Shifts some responsibility for oversight and enforcement to licensing boards and the commissioner of health.
Relevant Terms - informed consent - fertility - fertility preservation - family building - fertility specialist - health care provider - medical treatment - patient - health-related licensing board - commissioner of health - disciplinary action - consult with a fertility specialist - monitoring compliance
Bill text versions
- Introduction PDF PDF file
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| February 17, 2026 | Senate | Action | Introduction and first reading | ||
| February 17, 2026 | Senate | Action | Referred to | Health and Human Services |
Citations
[
{
"analysis": {
"added": [],
"removed": [],
"summary": "This bill references Minnesota Statutes chapter 144 as the codification for the proposed new informed-consent provision related to medical treatments that may affect fertility.",
"modified": []
},
"citation": "144",
"subdivision": ""
}
]